I really appreciate that Ossium has challenged me in ways that totally throw me out of my comfort zone. It's a wonderful place to learn and grow.
Brian Johnstone
Vice President, Research
Working At Ossium
Who We Are
At Ossium, we believe that science is humanity’s best weapon in the fight against disease, and we embrace the challenge of mobilizing the world’s healthcare ecosystem to win that fight. In pursuit of this goal, we empower our employees, maintain the highest standards of excellence, and are a force for good.
Kevin Caldwell
CEO, Co-Founder & President
Listen to Kevin Speak About Ossium’s Vision.
Impact
We are mission-driven and results-oriented. We believe that a healthier world is a better one and that our work should drive positive change.
Truth
Embracing the truth empowers us to learn from both our successes and our mistakes. We follow the data wherever it leads.
Ownership
We hold ourselves and each other to the highest bar. We care deeply about the work we do.
Grit
Each obstacle we encounter in pursuit of a healthier future only sharpens our resolve. We understand that our vision is worth fighting for.
Inside Look
Day in the Life
Recovery Services
These donor tissue recovery experts work with our OPO partners to continuously improve our tissue recovery processes. They are masters of Ossium’s recovery protocols and practices.
Clinical Production
These processing experts make our cell therapy products. They are skilled in tissue processing, cell processing, and cryopreservation.
Clinical
These clinical trial experts advance our clinical program by designing and implementing study protocols, managing research sites, and analyzing clinical trial data. Their work is critical in navigating the complex process of bringing innovative, life-saving treatments to patients in support of Ossium’s mission to improve the health, vitality, and longevity of human beings through bioengineering.
Quality Assurance
These Quality Assurance experts play a crucial role in preventing, detecting, and correcting defects and errors, fostering trust among patients and customers. They develop robust systems that ensure processes and products consistently meet established regulations and standards.
Words from the Team
Brian Johnstone
Vice President, Research
For the past 20 years, Dr. Johnstone has been actively involved in translating adult stem cell therapies into treatments for a host of diseases affecting the major organs of the body. In 2004, he co-authored one of the first studies demonstrating the potential for treating cardiovascular diseases with novel adult stem cells isolated from fat. At Ossium, Dr. Johnstone leads the Research organization, driving innovation and translating scientific discoveries into practical applications that advance the company mission.
Dr. Johnstone co-founded NeuroFx, an early-stage biotech firm developing a novel therapy for neurological disorders. Dr. Johnstone led the R&D program at NeuroFx for two years, where he was directly responsible for preclinical and chemistry, manufacturing, and controls development activities. He continues to act as an advisor for NeuroFx. Additionally, Dr. Johnstone has formed two other biotech companies: Chemigen, which is developing a small molecule drug for treating Lou Gehrig’s disease, and EmphyMab Biotech (now Allinaire), which is developing biologics to treat serious lung diseases.
Before becoming an entrepreneur, Dr. Johnstone was an early employee at Sangamo Biosciences for 6 years. During this time, he managed the preclinical development program for their lead gene therapy candidate for cardiovascular diseases, which was promoted to clinical testing. Dr. Johnstone received his PhD from the University of Maryland, College Park, and completed a postdoctoral fellowship at the University of California, Los Angeles.
I was introduced to Ossium early on while working at an OPO, and I was immediately drawn to the mission and the groundbreaking work. Even now, I remain consistently impressed by the impactful work we do daily and am in awe of the exceptional expertise and dedication of my colleagues.
Abby Brar
Associate Director, Donation Compliance
Abby Brar
Associate Director, Donation Compliance
One thing that stands out to me at Ossium is how much care and energy go into ensuring the highest quality of our products. As a scientist, I find it inspiring to be part of a company that is deeply data-driven and grounded in truth. It makes me proud to know that our work is not only rigorous but truly meaningful.
Dongsheng Gu
Principal Investigator, CLIA Technical Consultant
Dongsheng Gu
Principal Investigator, CLIA Technical Consultant
Two Locations, One Mission
Open Positions
At Ossium, we’re always looking for talented, mission-driven people.